Saline Infusion Sonography and Office Hysteroscopy to Assess Endometrial Morbidity Associated with Tamoxifen Intake

Garuti, Giancarlo; Cellani, Fulvia; Grossi, Francesco; Colonnelli, Monica; Centinaio, Giovanna; Luerti, Massimo

doi:10.1006/gyno.2002.6783

Cited by 25 publications

(9 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…36 This prevalence of pathology is only a little higher than the baseline rate of abnormalities detected in the present study, suggesting a general overestimation of Bdrug-induced[ endometrial morbidity found in studies that did not take into account pretreatment findings.…”

Section: Discussioncontrasting

confidence: 72%

Baseline hysteroscopic assessment of endometrium in asymptomatic postmenopausal women with estrogen receptor–positive breast cancer

et al. 2013

View full text Add to dashboard Cite

show abstract

Section: Discussioncontrasting

confidence: 72%

Baseline hysteroscopic assessment of endometrium in asymptomatic postmenopausal women with estrogen receptor–positive breast cancer

et al. 2013

View full text Add to dashboard Cite

show abstract

“…The mean values (95% CI) for the HADS scores in the false positive group were 9.9 (20.4-20.1) at baseline, 9.0 (20.9-18.9) at 3 months, and 8.6 (0. [8][9][10][11][12][13][14][15][16].36) at 6 months. The mean values (95% CI) for the HADS scores in nonfalse positive group were 12.7 (4.7-20.7) at baseline, 14.0 (4.3-23.7) at 3 months, and 11.3 (3.0-19.6) at 6 months.…”

Section: Resultsmentioning

confidence: 94%

“…The ''gold standard'' endometrial assessment in symptomatic women has traditionally been with hysteroscopy and endometrial biopsy. Evidence supports this as the most sensitive and specific diagnostic tool in the pre-and postmenopausal population (11)(12)(13)(14) .…”

mentioning

confidence: 83%

Does a “one-stop” gynecology screening clinic for women in hereditary nonpolyposis colorectal cancer families have an impact on their psychological morbidity and perception of health?

Wood¹,

Munot²,

Sheridan

et al. 2008

Int J Gynecol Cancer

View full text Add to dashboard Cite

Screening programs can reduce the burden of disease, however, they can be associated with raised levels of anxiety. The risk of endometrial and ovarian cancer is increased in hereditary nonpolyposis colorectal cancer (HNPCC). There is no prospective evidence to support screening for gynecological disease in HNPCC, however, current recommendations include the use of ultrasound and endometrial biopsy. This study assesses the impact of screening for gynecological cancer on self-reported symptoms of anxiety, depression, and perceptions of health. Women from HNPCC families attending gynecological screening (n = 26) completed the Hospital Anxiety and Depression Scale and the ShortForm36v2 questionnaires prior to screening with transvaginal ultrasound, outpatient/office hysteroscopy, endometrial biopsy, and ovarian tumor marker assessment (CA125). The same questionnaires were completed at 3 and 6 months following screening (15/26). Women in HNPCC families attending for gynecological screening did not have excess symptoms of anxiety or depression at baseline in subjective comparison to other populations. The process of screening and false positive screening results had no significant impact on symptoms of anxiety and depression or perceptions of health. We conclude that within the limitations of analysis in this small study group, screening for gynecological disease in HNPCC does not appear to be associated with any psychological morbidity.

show abstract

“…A recent comparison of saline infusion sonography and office hysteroscopy revealed similar ratings of patients' pelvic pain during the procedures. Sensitivity and specificity coefficients as well as negative and positive predictive values were higher for the office hysteroscopy [43]. …”

Section: Early Detectionmentioning

confidence: 99%

Untitled

et al. 2004

View full text Add to dashboard Cite

In spite of the overall good prognosis during the early stages of the disease, the survival is poor in advanced stages or recurrences. Diagnostic measures are very well able to detect asymptomatic recurrences. These only seem justified if patients' chances are likely to improve, otherwise such measures increases costs as well as decrease the patients' quality of life. To date neither current nor improved concepts of endocrine treatment or chemotherapy have been able to substantially increase patients' chances of survival. Therefore, newer concepts into the use of antibodies e.g. trastuzumab in HER2-overexpressing tumors and the newer endocrine compounds will need to be investigated. Furthermore, it would seem highly desirable if future studies were to identify valid criteria for an individualized management, thereby maximizing the benefits and minimizing the risks.

show abstract

Saline Infusion Sonography and Office Hysteroscopy to Assess Endometrial Morbidity Associated with Tamoxifen Intake

Cited by 25 publications

References 29 publications

Baseline hysteroscopic assessment of endometrium in asymptomatic postmenopausal women with estrogen receptor–positive breast cancer

Baseline hysteroscopic assessment of endometrium in asymptomatic postmenopausal women with estrogen receptor–positive breast cancer

Does a “one-stop” gynecology screening clinic for women in hereditary nonpolyposis colorectal cancer families have an impact on their psychological morbidity and perception of health?

Untitled

Contact Info

Product

Resources

About